Cite
MLA Citation
Richard R. Furman et al.. “Extended follow-up with the Bruton's tyrosine kinase inhibitor ibrutinib in previously treated Waldenström's macroglobulinemia.” Leukemia & lymphoma, vol. 58, no. 6, 2017, pp. 1502–1505. http://access.bl.uk/ark:/81055/vdc_100042870929.0x00005c